Product & regulatory approvals

Gates that opened: regulatory and product approvals — drug approvals, licences, clearances — disclosed to the exchanges inside the window. The approval filing is linked on every row.

CompanyWhy it’s here — the filingReaction 1d / 1w / 1mPriceMcapP/EROCERev YoY
LupinPharmaceuticalsLupin launches world's first triple combo COPD inhaler in India6 Oct 2026Regulatory Product Approval×2+0.8% — —₹1,93788,565 Cr16.0vs 31.226.7%+32.0%
Vedanta Aluminium MetalVAMLVedanta Aluminium posts record Q2 production across all segments3 Oct 2026Regulatory Product Approval-0.3% — —₹3741.46 L Cr26.0——
Godrej PropertiesResidential Commercial ProjectsMoEFCC revokes environmental clearance for Godrej Eternia Chandigarh project1 Oct 2026Regulatory Product Approval+0.9% — —₹1,53446,207 Cr28.9vs 20.811.4%+16.5%
Aurobindo PharmaPharmaceuticalsAcrotech launches ADQUEY in U.S., sets up dermatology unit30 Sept 2026Regulatory Product Approval+0.2% — —₹1,64594,653 Cr25.7vs 31.212.6%+16.3%
ZF Com VE CTR SYS IndAuto Components & EquipmentsZF CVCS India secures NABL accreditation for Hemi Anechoic Chamber30 Sept 2026Regulatory Product Approval-6.0% — —₹2,08123,686 Cr9.6vs 26.718.4%+9.3%
Motilal Oswal FinStockbroking & AlliedMotilal Oswal subsidiary gets SEBI custodian licence23 Sept 2026Regulatory Product Approval×2-1.2% +3.9% —₹1,01461,076 Cr30.8vs 15.8—+25.2%
PI IndustriesPesticides & AgrochemicalsPI Industries gets regulatory registration for new insecticide Pioxaniliprole21 Sept 2026Regulatory Product Approval+2.7% -3.9% —₹2,10031,920 Cr27.3vs 19.614.5%-10.4%
Alkem LaboratoriesPharmaceuticalsAlkem launches NeuCeno for partial-onset seizures in India16 Sept 2026Regulatory Product Approval+3.3% +2.2% —₹5,25062,758 Cr29.1vs 31.217.8%+10.9%
GMR AirportsAirport & Airport servicesGMR Airports Aug'26 Traffic: 9.4 mn Pax, Up 0.9% YoY15 Sept 2026Regulatory Product Approval+2.2% +5.4% —₹87.7792,676 Cr190.80.8%+23.7%
Anand Rathi WealthFinancial Products DistributorAnand Rathi subsidiary gets IFSCA fund management registration at GIFT City14 Sept 2026Regulatory Product Approval-0.1% -1.9% —₹2,13935,515 Cr46.1vs 20.648.6%+17.5%
Shilpa MedicarePharmaceuticalsShilpa Medicare gets SEC nod for OERIS injectable marketing authorization11 Sept 2026Regulatory Product Approval-3.4% +10.1% —₹1,02820,102 Cr67.3vs 31.210.3%+44.9%
Acutaas ChemicalsPharmaceuticalsAcutaas Chemicals gets patent for 2,4-Dimethylthiophenol process, total patents now 1110 Sept 2026Regulatory Product Approval-5.6% -5.5% —₹3,05024,971 Cr64.7vs 31.227.5%+59.1%
Sterlite TechnologiesSTLTECHSTL launches plenum-rated fiber trunk assemblies for AI data centers10 Sept 2026Regulatory Product Approval-0.6% +0.7% —₹1,00549,245 Cr202.23.0%+87.4%
How this list is built

A company appears when an NSE/BSE filing inside the last 30 days carries one of these classifier signals (minimum importance: Medium): Regulatory Product Approval. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.

MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.